B. Riley analyst Raj Sharma lowered the firm’s price target on Aspen Group to $1.50 from $3 and keeps a Buy rating on the shares ahead of the fiscal Q2 results on December 13. Aspen is "likely to forgo any ambitions" of pursuing pre-licensure programs, restructuring to cut its expense structure, and return to its "profitable roots" of online post-licensure and family nurse practitioner education, Sharma tells investors in a research note. The analyst reduced the target to account for the change in business model and the uncertainty surrounding Aspen.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ASPU:
